Healthcare Sector Stocks
The Healthcare sector has a total of 1060 stocks, with a combined market cap of $8.32 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.36.
Market Cap
8.32T
Revenue
4.59T
Profits
201.2B
PE Ratio
41.36
Profit Margin
4.38%
Dividend Yield
0.43%
1061 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 928.88B | 2.24% | 2,286,424 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 557.82B | 1.05% | 5,236,642 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 378.98B | 1.04% | 3,813,675 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 347.35B | -0.21% | 3,087,824 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 291.18B | 1.22% | 2,192,608 | 60.44B |
| 6 | NVS | Novartis AG | 288.29B | 0.87% | 965,734 | 56.58B |
| 7 | MRK | Merck & Co., Inc. | 286.20B | 2.55% | 7,392,749 | 65.77B |
| 8 | NVO | Novo Nordisk A/S | 195.28B | -1.51% | 11,571,776 | 50.57B |
| 9 | AMGN | Amgen Inc. | 182.11B | 1.76% | 2,000,826 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 167.00B | -0.54% | 2,012,621 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 162.02B | -0.15% | 4,919,895 | 29.74B |
| 12 | ISRG | Intuitive Surgical, Inc. | 155.76B | -2.06% | 2,087,540 | 10.58B |
| 13 | ABT | Abbott Laboratories | 152.88B | -0.69% | 8,522,005 | 45.13B |
| 14 | PFE | Pfizer Inc. | 147.90B | 0.62% | 20,153,460 | 63.32B |
| 15 | DHR | Danaher Corporation | 122.68B | 1.29% | 4,231,474 | 24.78B |
| 16 | BMY | Bristol-Myers Squibb Company | 121.61B | 1.73% | 8,449,495 | 48.48B |
| 17 | SYK | Stryker Corporation | 120.18B | -2.49% | 2,890,559 | 25.27B |
| 18 | CVS | CVS Health Corporation | 119.07B | 0.04% | 6,478,499 | 405.62B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 110.03B | 0.72% | 1,395,086 | 12.22B |
| 20 | SNY | Sanofi | 107.83B | 0.56% | 2,236,184 | 54.60B |
| 21 | GSK | GSK plc | 102.44B | 1.48% | 2,102,373 | 43.29B |
| 22 | MDT | Medtronic plc | 100.34B | - | 9,225,537 | 35.48B |
| 23 | MCK | McKesson Corporation | 92.14B | 1.57% | 1,640,751 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 87.09B | -1.04% | 2,356,468 | 76.39B |
| 25 | BSX | Boston Scientific Corporation | 84.95B | 0.85% | 12,837,866 | 20.61B |
| 26 | ELV | Elevance Health, Inc. | 84.65B | -1.61% | 1,253,935 | 200.42B |
| 27 | CI | The Cigna Group | 74.60B | -0.38% | 1,158,397 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 65.38B | -1.10% | 1,178,480 | 14.92B |
| 29 | COR | Cencora, Inc. | 51.64B | 0.26% | 1,300,707 | 328.68B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 51.41B | -1.20% | 3,358,196 | 28.34B |
| 31 | ARGX | argenx SE | 50.88B | 1.49% | 429,771 | 4.74B |
| 32 | MDLN | Medline Inc. | 48.74B | 2.34% | 16,479,459 | 29.14B |
| 33 | EW | Edwards Lifesciences Corporation | 47.91B | 0.28% | 3,727,026 | 6.30B |
| 34 | CAH | Cardinal Health, Inc. | 46.98B | 0.69% | 2,062,844 | 250.74B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 43.63B | -0.09% | 430,634 | 4.45B |
| 36 | HLN | Haleon plc | 40.65B | 0.43% | 6,427,364 | 14.85B |
| 37 | BDX | Becton, Dickinson and Company | 40.30B | -0.48% | 1,986,160 | 22.23B |
| 38 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.12B | 0.68% | 650,227 | 4.29B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 39.78B | -0.47% | 4,604,954 | 17.35B |
| 40 | HUM | Humana Inc. | 36.46B | -0.14% | 939,152 | 137.20B |
| 41 | ONC | BeOne Medicines AG | 34.42B | 0.29% | 246,298 | 5.70B |
| 42 | ZTS | Zoetis Inc. | 33.57B | 0.45% | 8,561,837 | 9.53B |
| 43 | WAT | Waters Corporation | 33.48B | -0.10% | 641,404 | 3.77B |
| 44 | ALC | Alcon Inc. | 32.88B | 0.97% | 2,357,354 | 10.63B |
| 45 | RVMD | Revolution Medicines, Inc. | 32.68B | 2.26% | 1,844,798 | - |
| 46 | A | Agilent Technologies, Inc. | 32.44B | 0.89% | 2,416,761 | 7.07B |
| 47 | RPRX | Royalty Pharma plc | 30.84B | 0.92% | 2,826,461 | 2.44B |
| 48 | RMD | ResMed Inc. | 30.31B | -0.42% | 1,115,598 | 5.54B |
| 49 | GEHC | GE HealthCare Technologies Inc. | 29.26B | 0.11% | 5,107,801 | 20.98B |
| 50 | NTRA | Natera, Inc. | 29.17B | -0.60% | 1,490,593 | 2.50B |
| 51 | CNC | Centene Corporation | 28.53B | -0.88% | 3,330,913 | 178.33B |
| 52 | IQV | IQVIA Holdings Inc. | 28.04B | -2.03% | 2,077,462 | 16.63B |
| 53 | BIIB | Biogen Inc. | 27.97B | 0.89% | 1,252,488 | 9.94B |
| 54 | DXCM | DexCom, Inc. | 27.74B | 0.64% | 9,080,402 | 4.82B |
| 55 | VEEV | Veeva Systems Inc. | 25.83B | -4.06% | 1,770,362 | 3.20B |
| 56 | PHG | Koninklijke Philips N.V. | 25.61B | 1.53% | 1,101,884 | 20.34B |
| 57 | UTHR | United Therapeutics Corporation | 24.02B | 0.34% | 418,826 | 3.17B |
| 58 | INSM | Insmed Incorporated | 23.74B | 1.50% | 3,689,606 | 819.56M |
| 59 | BNTX | BioNTech SE | 22.99B | 0.63% | 570,371 | 3.23B |
| 60 | WST | West Pharmaceutical Services, Inc. | 22.33B | 3.48% | 743,505 | 3.22B |
| 61 | ROIV | Roivant Sciences Ltd. | 22.21B | -4.72% | 10,110,718 | 8.26M |
| 62 | MTD | Mettler-Toledo International Inc. | 22.04B | 0.72% | 143,730 | 4.09B |
| 63 | ILMN | Illumina, Inc. | 21.91B | 2.05% | 1,383,176 | 4.39B |
| 64 | STE | STERIS plc | 21.54B | 1.71% | 889,467 | 5.94B |
| 65 | DGX | Quest Diagnostics Incorporated | 21.46B | 0.04% | 453,021 | 11.28B |
| 66 | LH | Labcorp Holdings Inc. | 20.97B | -0.65% | 537,934 | 14.14B |
| 67 | INCY | Incyte Corporation | 19.46B | 0.34% | 765,519 | 5.36B |
| 68 | VTRS | Viatris Inc. | 19.17B | -0.78% | 8,169,244 | 14.56B |
| 69 | MRNA | Moderna, Inc. | 18.75B | -1.79% | 4,784,610 | 2.23B |
| 70 | ZBH | Zimmer Biomet Holdings, Inc. | 16.50B | -0.08% | 1,895,406 | 8.41B |
| 71 | GMAB | Genmab A/S | 16.39B | -0.59% | 1,050,389 | 3.90B |
| 72 | GH | Guardant Health, Inc. | 15.65B | 2.64% | 4,934,104 | 1.08B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 15.64B | 0.54% | 1,037,006 | 3.10B |
| 74 | ASND | Ascendis Pharma A/S | 15.37B | 2.56% | 410,268 | 998.25M |
| 75 | THC | Tenet Healthcare Corporation | 15.33B | -5.02% | 1,464,509 | 21.46B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.02B | 0.16% | 595,593 | 4.44B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 13.77B | 3.02% | 2,284,549 | 579.96M |
| 78 | SMMT | Summit Therapeutics Inc. | 13.56B | -2.35% | 3,332,149 | - |
| 79 | RGC | Regencell Bioscience Holdings Limited | 13.35B | -1.42% | 43,768 | - |
| 80 | SOLV | Solventum Corporation | 13.29B | 0.81% | 1,216,848 | 8.26B |
| 81 | SNN | Smith & Nephew plc | 13.08B | -0.81% | 721,680 | 6.16B |
| 82 | PEN | Penumbra, Inc. | 12.90B | 0.16% | 427,197 | 1.45B |
| 83 | DVA | DaVita Inc. | 12.75B | 0.91% | 521,498 | 13.84B |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 12.52B | 0.96% | 2,295,135 | 1.06B |
| 85 | EXEL | Exelixis, Inc. | 12.48B | -0.50% | 1,485,824 | 2.38B |
| 86 | MEDP | Medpace Holdings, Inc. | 12.28B | 1.95% | 320,229 | 2.68B |
| 87 | COO | The Cooper Companies, Inc. | 12.26B | 1.78% | 2,270,969 | 4.15B |
| 88 | FMS | Fresenius Medical Care AG | 12.06B | 1.35% | 634,344 | 22.32B |
| 89 | AXSM | Axsome Therapeutics, Inc. | 12.02B | 1.31% | 590,616 | 708.24M |
| 90 | BTSG | BrightSpring Health Services, Inc. | 11.93B | -1.02% | 2,535,259 | 13.65B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.84B | 0.02% | 203,583 | 1.13B |
| 92 | ALGN | Align Technology, Inc. | 11.68B | -0.21% | 1,163,624 | 4.10B |
| 93 | GMED | Globus Medical, Inc. | 11.49B | 0.69% | 2,515,944 | 3.10B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.39B | -0.59% | 1,836,455 | 3.58B |
| 95 | PODD | Insulet Corporation | 10.87B | 0.19% | 1,030,504 | 2.90B |
| 96 | ELAN | Elanco Animal Health Incorporated | 10.65B | 2.25% | 6,071,809 | 4.89B |
| 97 | RVTY | Revvity, Inc. | 10.64B | 0.61% | 1,286,963 | 2.90B |
| 98 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.64B | -2.07% | 1,580,121 | 622.01M |
| 99 | CYTK | Cytokinetics, Incorporated | 10.60B | -0.90% | 1,775,131 | 105.82M |
| 100 | BMRN | BioMarin Pharmaceutical Inc. | 10.46B | 7.77% | 4,570,994 | 3.24B |
| 101 | EHC | Encompass Health Corporation | 10.36B | -1.45% | 586,344 | 6.07B |
| 102 | ENSG | The Ensign Group, Inc. | 9.95B | -3.69% | 819,368 | 5.27B |
| 103 | UHS | Universal Health Services, Inc. | 9.83B | -1.14% | 968,436 | 17.76B |
| 104 | BAX | Baxter International Inc. | 9.83B | 1.39% | 7,329,177 | 11.32B |
| 105 | PRAX | Praxis Precision Medicines, Inc. | 9.77B | 4.45% | 286,329 | 7.46M |
| 106 | ABVX | ABIVAX Société Anonyme | 9.70B | 3.44% | 1,395,006 | 5.37M |
| 107 | MOH | Molina Healthcare, Inc. | 9.44B | -0.54% | 726,289 | 43.10B |
| 108 | MASI | Masimo Corporation | 9.35B | -0.08% | 1,180,162 | 1.56B |
| 109 | KRYS | Krystal Biotech, Inc. | 8.97B | 0.72% | 171,299 | 417.30M |
| 110 | ICLR | ICON Public Limited Company | 8.91B | 1.33% | 371,709 | 8.10B |
| 111 | HSIC | Henry Schein, Inc. | 8.37B | 0.37% | 1,006,747 | 13.38B |
| 112 | TEM | Tempus AI, Inc. | 8.35B | 1.33% | 3,804,812 | 1.36B |
| 113 | GKOS | Glaukos Corporation | 8.16B | -3.33% | 1,308,954 | 551.35M |
| 114 | HALO | Halozyme Therapeutics, Inc. | 8.13B | -0.67% | 1,750,540 | 1.51B |
| 115 | IBRX | ImmunityBio, Inc. | 8.11B | -3.85% | 20,515,077 | 140.98M |
| 116 | NUVL | Nuvalent, Inc. | 8.00B | -1.06% | 372,019 | - |
| 117 | BIO | Bio-Rad Laboratories, Inc. | 7.67B | -0.39% | 228,293 | 2.59B |
| 118 | CRL | Charles River Laboratories International, Inc. | 7.65B | 1.81% | 867,752 | 4.03B |
| 119 | TECH | Bio-Techne Corporation | 7.42B | 1.43% | 2,315,428 | 1.21B |
| 120 | ATR | AptarGroup, Inc. | 7.37B | 0.22% | 340,562 | 3.87B |
| 121 | HQY | HealthEquity, Inc. | 7.31B | -1.21% | 759,031 | 1.31B |
| 122 | QGEN | Qiagen N.V. | 7.22B | -0.57% | 1,233,738 | 2.10B |
| 123 | IMVT | Immunovant, Inc. | 7.01B | -4.02% | 4,606,210 | - |
| 124 | CELC | Celcuity Inc. | 6.95B | 1.56% | 660,702 | - |
| 125 | BRKR | Bruker Corporation | 6.85B | 1.63% | 1,624,491 | 3.46B |
| 126 | PCVX | Vaxcyte, Inc. | 6.84B | 0.47% | 1,180,257 | - |
| 127 | GRFS | Grifols, S.A. | 6.77B | -0.98% | 634,248 | 8.58B |
| 128 | OSCR | Oscar Health, Inc. | 6.67B | -5.47% | 8,625,677 | 13.30B |
| 129 | KYMR | Kymera Therapeutics, Inc. | 6.63B | -0.05% | 407,642 | 51.48M |
| 130 | PTGX | Protagonist Therapeutics, Inc. | 6.56B | 1.12% | 402,918 | 74.06M |
| 131 | SYRE | Spyre Therapeutics, Inc. | 6.45B | 3.34% | 730,319 | - |
| 132 | CORT | Corcept Therapeutics Incorporated | 6.41B | 1.07% | 874,619 | 769.10M |
| 133 | RGEN | Repligen Corporation | 6.39B | 1.46% | 1,042,652 | 763.34M |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.18B | -0.50% | 539,529 | 217.17M |
| 135 | APGE | Apogee Therapeutics, Inc. | 6.18B | 1.30% | 369,896 | - |
| 136 | CNTA | Centessa Pharmaceuticals plc | 6.16B | 0.15% | 1,744,890 | 15.00M |
| 137 | ALKS | Alkermes plc | 6.16B | -0.08% | 1,692,645 | 1.56B |
| 138 | LNTH | Lantheus Holdings, Inc. | 6.15B | -1.69% | 711,007 | 1.55B |
| 139 | MIRM | Mirum Pharmaceuticals, Inc. | 6.14B | 3.84% | 922,851 | 569.61M |
| 140 | PACS | PACS Group, Inc. | 5.98B | 2.08% | 904,594 | 5.43B |
| 141 | TFX | Teleflex Incorporated | 5.84B | -2.43% | 624,431 | 2.13B |
| 142 | CHE | Chemed Corporation | 5.84B | -0.01% | 219,883 | 2.54B |
| 143 | PTCT | PTC Therapeutics, Inc. | 5.79B | -1.73% | 808,821 | 827.11M |
| 144 | BLCO | Bausch + Lomb Corporation | 5.76B | -0.31% | 455,590 | 5.21B |
| 145 | SRRK | Scholar Rock Holding Corporation | 5.72B | -1.36% | 1,051,979 | - |
| 146 | CGON | CG Oncology, Inc. | 5.70B | -0.26% | 685,251 | 5.07M |
| 147 | BLTE | Belite Bio, Inc | 5.67B | 0.62% | 134,304 | - |
| 148 | COGT | Cogent Biosciences, Inc. | 5.57B | -1.05% | 1,170,899 | - |
| 149 | TGTX | TG Therapeutics, Inc. | 5.56B | -1.31% | 1,264,923 | 700.35M |
| 150 | HIMS | Hims & Hers Health, Inc. | 5.56B | 4.21% | 13,811,369 | 2.37B |
| 151 | LQDA | Liquidia Corporation | 5.51B | 0.32% | 1,047,721 | 288.07M |
| 152 | AVTR | Avantor, Inc. | 5.37B | -0.13% | 6,345,138 | 6.55B |
| 153 | XENE | Xenon Pharmaceuticals Inc. | 5.23B | -1.02% | 1,148,603 | 7.50M |
| 154 | LEGN | Legend Biotech Corporation | 5.20B | -0.46% | 1,535,378 | 1.14B |
| 155 | DNTH | Dianthus Therapeutics, Inc. | 4.90B | 1.03% | 514,505 | 1.34M |
| 156 | STVN | Stevanato Group S.p.A. | 4.87B | 0.56% | 193,683 | 1.39B |
| 157 | CRSP | CRISPR Therapeutics AG | 4.81B | 2.78% | 1,429,877 | 4.10M |
| 158 | CAI | Caris Life Sciences, Inc. | 4.51B | 1.53% | 2,137,063 | 907.29M |
| 159 | SHC | Sotera Health Company | 4.48B | 1.03% | 2,073,446 | 1.19B |
| 160 | LGND | Ligand Pharmaceuticals Incorporated | 4.45B | 2.03% | 153,804 | 274.48M |
| 161 | MANE | Veradermics, Incorporated | 4.31B | -0.59% | 295,297 | - |
| 162 | RDNT | RadNet, Inc. | 4.28B | 0.42% | 537,825 | 2.14B |
| 163 | HNGE | Hinge Health, Inc. | 4.27B | 0.69% | 1,101,431 | 646.34M |
| 164 | NAMS | NewAmsterdam Pharma Company N.V. | 4.17B | -0.22% | 1,059,860 | 22.57M |
| 165 | TVTX | Travere Therapeutics, Inc. | 4.16B | 2.87% | 1,324,475 | 536.20M |
| 166 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.13B | -1.16% | 767,557 | 754.05M |
| 167 | LIVN | LivaNova PLC | 4.05B | -0.09% | 582,591 | 1.43B |
| 168 | AMRX | Amneal Pharmaceuticals, Inc. | 3.96B | 1.55% | 1,653,494 | 3.05B |
| 169 | BLLN | BillionToOne, Inc. | 3.96B | 3.24% | 725,353 | 354.54M |
| 170 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.91B | 2.23% | 740,768 | 18.07M |
| 171 | IRTC | iRhythm Holdings, Inc. | 3.87B | 0.74% | 234,154 | 787.85M |
| 172 | NVST | Envista Holdings Corporation | 3.85B | -0.59% | 3,594,065 | 2.81B |
| 173 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | 0.10% | 2,343,487 | 596.96M |
| 174 | MMSI | Merit Medical Systems, Inc. | 3.80B | -1.33% | 444,632 | 1.54B |
| 175 | TWST | Twist Bioscience Corporation | 3.66B | 9.64% | 2,025,777 | 409.48M |
| 176 | ACAD | ACADIA Pharmaceuticals Inc. | 3.65B | 1.77% | 1,640,419 | 1.10B |
| 177 | WAY | Waystar Holding Corp. | 3.61B | -1.95% | 1,494,966 | 1.16B |
| 178 | ERAS | Erasca, Inc. | 3.61B | 4.36% | 3,108,375 | - |
| 179 | VCYT | Veracyte, Inc. | 3.61B | - | 1,114,467 | 541.74M |
| 180 | VKTX | Viking Therapeutics, Inc. | 3.56B | 4.21% | 2,000,490 | - |
| 181 | DOCS | Doximity, Inc. | 3.55B | -2.37% | 3,779,008 | 644.86M |
| 182 | ORKA | Oruka Therapeutics, Inc. | 3.54B | -3.26% | 1,199,738 | - |
| 183 | OGN | Organon & Co. | 3.52B | -0.30% | 3,498,465 | 6.16B |
| 184 | EWTX | Edgewise Therapeutics, Inc. | 3.52B | -0.40% | 519,050 | - |
| 185 | TLX | Telix Pharmaceuticals Limited | 3.42B | -0.10% | 107,488 | 803.79M |
| 186 | ALHC | Alignment Healthcare, Inc. | 3.38B | -1.77% | 3,201,222 | 4.26B |
| 187 | OPCH | Option Care Health, Inc. | 3.38B | -3.19% | 2,786,166 | 5.67B |
| 188 | MMED | MiniMed Group, Inc. | 3.29B | 0.77% | 617,866 | 2.99B |
| 189 | ICUI | ICU Medical, Inc. | 3.28B | 1.55% | 276,389 | 2.16B |
| 190 | CON | Concentra Group Holdings Parent, Inc. | 3.27B | 0.67% | 613,683 | 2.23B |
| 191 | BKD | Brookdale Senior Living Inc. | 3.19B | 0.30% | 2,801,923 | 3.00B |
| 192 | TXG | 10x Genomics, Inc. | 3.13B | 2.92% | 4,060,526 | 638.78M |
| 193 | TNGX | Tango Therapeutics, Inc. | 3.13B | 2.56% | 2,578,502 | 56.99M |
| 194 | DNLI | Denali Therapeutics Inc. | 3.06B | 2.50% | 1,279,879 | - |
| 195 | NHC | National HealthCare Corporation | 3.06B | -1.76% | 133,110 | 1.53B |
| 196 | ITGR | Integer Holdings Corporation | 3.06B | -1.63% | 532,070 | 1.86B |
| 197 | WRBY | Warby Parker Inc. | 3.01B | 0.20% | 2,044,692 | 890.57M |
| 198 | RCUS | Arcus Biosciences, Inc. | 3.00B | 0.55% | 405,609 | 236.00M |
| 199 | GRAL | GRAIL, Inc. | 2.91B | 2.77% | 433,847 | 156.12M |
| 200 | LFST | LifeStance Health Group, Inc. | 2.89B | -2.86% | 2,055,074 | 1.49B |
| 201 | HAE | Haemonetics Corporation | 2.88B | 4.00% | 1,182,540 | 1.33B |
| 202 | DYN | Dyne Therapeutics, Inc. | 2.87B | -1.08% | 1,773,481 | - |
| 203 | SUPN | Supernus Pharmaceuticals, Inc. | 2.87B | 1.42% | 529,463 | 776.83M |
| 204 | PRVA | Privia Health Group, Inc. | 2.85B | -2.33% | 671,688 | 2.25B |
| 205 | ALMS | Alumis Inc. | 2.83B | 0.59% | 874,022 | 8.40M |
| 206 | GPCR | Structure Therapeutics Inc. | 2.76B | 5.21% | 415,168 | - |
| 207 | BEAM | Beam Therapeutics Inc. | 2.75B | 2.07% | 1,980,318 | 164.01M |
| 208 | TARS | Tarsus Pharmaceuticals, Inc. | 2.73B | -2.02% | 293,733 | 535.08M |
| 209 | KLRA | Kailera Therapeutics, Inc. | 2.73B | 4.98% | 362,106 | - |
| 210 | ARQT | Arcutis Biotherapeutics, Inc. | 2.63B | 2.66% | 1,375,272 | 415.62M |
| 211 | RLAY | Relay Therapeutics, Inc. | 2.62B | 4.92% | 10,417,788 | 10.68M |
| 212 | IMNM | Immunome, Inc. | 2.60B | 6.64% | 1,586,305 | 4.02M |
| 213 | IDYA | IDEAYA Biosciences, Inc. | 2.60B | -0.37% | 642,470 | 225.27M |
| 214 | ELVN | Enliven Therapeutics, Inc. | 2.57B | 0.93% | 918,325 | - |
| 215 | IRON | Disc Medicine, Inc. | 2.56B | 0.15% | 341,471 | - |
| 216 | HTFL | HeartFlow, Inc. | 2.52B | 6.65% | 970,941 | 191.42M |
| 217 | GMRS | GMR Solutions Inc. | 2.51B | -3.68% | 1,177,512 | 5.74B |
| 218 | MLYS | Mineralys Therapeutics, Inc. | 2.49B | 6.33% | 774,170 | - |
| 219 | DFTX | Definium Therapeutics, Inc. | 2.47B | 8.53% | 1,950,278 | - |
| 220 | VERA | Vera Therapeutics, Inc. | 2.47B | -0.77% | 527,711 | - |
| 221 | GRDN | Guardian Pharmacy Services, Inc. | 2.43B | 1.97% | 581,250 | 1.46B |
| 222 | CLDX | Celldex Therapeutics, Inc. | 2.40B | -1.04% | 904,362 | 865.00K |
| 223 | TMDX | TransMedics Group, Inc. | 2.38B | 1.25% | 987,073 | 635.89M |
| 224 | KOD | Kodiak Sciences Inc. | 2.34B | 3.29% | 464,012 | - |
| 225 | RARE | Ultragenyx Pharmaceutical Inc. | 2.33B | 1.45% | 1,272,123 | 670.00M |
| 226 | NKTR | Nektar Therapeutics | 2.31B | -1.31% | 584,841 | 55.63M |
| 227 | PBH | Prestige Consumer Healthcare Inc. | 2.28B | 2.20% | 606,128 | 1.09B |
| 228 | LMAT | LeMaitre Vascular, Inc. | 2.27B | -1.88% | 251,049 | 256.28M |
| 229 | ADPT | Adaptive Biotechnologies Corporation | 2.22B | -0.64% | 1,075,738 | 295.41M |
| 230 | AXGN | Axogen, Inc. | 2.20B | -3.23% | 503,765 | 238.11M |
| 231 | ZLAB | Zai Lab Limited | 2.15B | 1.54% | 427,466 | 453.28M |
| 232 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.13B | -4.23% | 4,042,370 | 885.72M |
| 233 | ACHC | Acadia Healthcare Company, Inc. | 2.12B | -4.36% | 4,621,210 | 3.37B |
| 234 | ESTA | Establishment Labs Holdings Inc. | 2.09B | 1.70% | 361,907 | 229.58M |
| 235 | HCM | HUTCHMED (China) Limited | 2.08B | 1.09% | 53,618 | 548.51M |
| 236 | NVCR | NovoCure Limited | 2.07B | 0.85% | 1,129,515 | 674.41M |
| 237 | SEM | Select Medical Holdings Corporation | 2.05B | 0.12% | 5,785,264 | 5.52B |
| 238 | BHC | Bausch Health Companies Inc. | 2.04B | -0.91% | 1,117,326 | 10.53B |
| 239 | TRVI | Trevi Therapeutics, Inc. | 2.01B | 2.02% | 957,430 | - |
| 240 | PHVS | Pharvaris N.V. | 2.00B | 3.70% | 308,788 | - |
| 241 | OMCL | Omnicell, Inc. | 1.99B | -2.15% | 600,417 | 1.23B |
| 242 | XRAY | DENTSPLY SIRONA Inc. | 1.99B | 0.91% | 5,273,449 | 3.68B |
| 243 | AUPH | Aurinia Pharmaceuticals Inc. | 1.99B | -2.83% | 919,930 | 298.30M |
| 244 | TYRA | Tyra Biosciences, Inc. | 1.96B | -1.23% | 609,654 | - |
| 245 | ADMA | ADMA Biologics, Inc. | 1.96B | -1.17% | 3,341,127 | 509.86M |
| 246 | VRDN | Viridian Therapeutics, Inc. | 1.95B | 0.34% | 1,530,376 | 70.92M |
| 247 | PGNY | Progyny, Inc. | 1.93B | -3.71% | 1,424,500 | 1.29B |
| 248 | NEOG | Neogen Corporation | 1.93B | 0.34% | 4,739,010 | 870.56M |
| 249 | MESO | Mesoblast Limited | 1.91B | 3.17% | 144,312 | 65.38M |
| 250 | CLOV | Clover Health Investments, Corp. | 1.90B | 0.28% | 5,518,734 | 2.21B |
| 251 | AAPG | Ascentage Pharma Group International | 1.90B | 4.45% | 4,807 | 82.08M |
| 252 | SION | Sionna Therapeutics, Inc. | 1.89B | 5.70% | 236,749 | - |
| 253 | NBTX | Nanobiotix S.A. | 1.88B | -6.90% | 111,303 | 38.27M |
| 254 | ASTH | Astrana Health, Inc. | 1.85B | -3.53% | 427,230 | 3.53B |
| 255 | STOK | Stoke Therapeutics, Inc. | 1.85B | -2.06% | 487,951 | 32.08M |
| 256 | OCS | Oculis Holding AG | 1.83B | 11.07% | 965,803 | 1.40M |
| 257 | ZYME | Zymeworks Inc. | 1.83B | 1.09% | 618,617 | 81.26M |
| 258 | LKFT | Lakefront Biotherapeutics NV | 1.83B | 1.39% | 193,846 | 1.20B |
| 259 | NRIX | Nurix Therapeutics, Inc. | 1.81B | 6.76% | 1,955,951 | 71.78M |
| 260 | OCUL | Ocular Therapeutix, Inc. | 1.80B | 2.37% | 2,313,061 | 52.04M |
| 261 | VCEL | Vericel Corporation | 1.80B | -0.71% | 1,071,925 | 292.09M |
| 262 | GENB | Generate Biomedicines, Inc. | 1.79B | 7.37% | 993,267 | 30.30M |
| 263 | SRPT | Sarepta Therapeutics, Inc. | 1.79B | -0.93% | 2,018,618 | 2.18B |
| 264 | SNDA | Sonida Senior Living, Inc. | 1.77B | 3.71% | 939,942 | 367.34M |
| 265 | PLSE | Pulse Biosciences, Inc. | 1.77B | -2.03% | 258,645 | 751.00K |
| 266 | HRMY | Harmony Biosciences Holdings, Inc. | 1.77B | -2.84% | 585,990 | 899.11M |
| 267 | ANAB | AnaptysBio, Inc. | 1.76B | 0.55% | 396,310 | 232.39M |
| 268 | RAPP | Rapport Therapeutics, Inc. | 1.76B | 2.74% | 321,008 | 20.00M |
| 269 | ANIP | ANI Pharmaceuticals, Inc. | 1.76B | 0.94% | 324,134 | 923.71M |
| 270 | SNDX | Syndax Pharmaceuticals, Inc. | 1.75B | -1.79% | 1,204,134 | 217.17M |
| 271 | UFPT | UFP Technologies, Inc. | 1.75B | 0.64% | 218,710 | 608.85M |
| 272 | NTLA | Intellia Therapeutics, Inc. | 1.73B | 0.90% | 4,426,587 | 66.09M |
| 273 | MD | Pediatrix Medical Group, Inc. | 1.73B | -4.09% | 872,363 | 1.93B |
| 274 | SGRY | Surgery Partners, Inc. | 1.72B | -1.48% | 1,044,760 | 3.34B |
| 275 | CAPR | Capricor Therapeutics, Inc. | 1.71B | 1.96% | 893,275 | 11.13M |
| 276 | AGIO | Agios Pharmaceuticals, Inc. | 1.71B | 1.02% | 522,741 | 66.05M |
| 277 | ADUS | Addus HomeCare Corporation | 1.71B | -0.53% | 158,171 | 1.45B |
| 278 | AVAH | Aveanna Healthcare Holdings Inc. | 1.67B | -0.13% | 1,003,453 | 2.52B |
| 279 | NUVB | Nuvation Bio Inc. | 1.67B | 6.21% | 4,084,173 | 143.05M |
| 280 | PVLA | Palvella Therapeutics, Inc. | 1.67B | 0.54% | 168,062 | - |
| 281 | IOVA | Iovance Biotherapeutics, Inc. | 1.65B | 4.52% | 10,581,630 | 285.61M |
| 282 | RXRX | Recursion Pharmaceuticals, Inc. | 1.65B | 5.07% | 13,081,443 | 66.41M |
| 283 | PRCT | PROCEPT BioRobotics Corporation | 1.65B | 2.92% | 1,407,990 | 322.02M |
| 284 | INVA | Innoviva, Inc. | 1.64B | -0.18% | 815,097 | 420.69M |
| 285 | STAA | STAAR Surgical Company | 1.63B | -0.79% | 1,241,091 | 290.38M |
| 286 | INBX | Inhibrx Biosciences, Inc. | 1.62B | 0.51% | 335,104 | 1.30M |
| 287 | GLUE | Monte Rosa Therapeutics, Inc. | 1.59B | 1.23% | 758,631 | 42.95M |
| 288 | TSHA | Taysha Gene Therapies, Inc. | 1.59B | 0.91% | 2,208,750 | 7.47M |
| 289 | ATAI | AtaiBeckley Inc. | 1.59B | 5.87% | 4,023,942 | 3.49M |
| 290 | PRGO | Perrigo Company plc | 1.57B | 1.70% | 2,240,168 | 4.18B |
| 291 | ABCL | AbCellera Biologics Inc. | 1.57B | 12.47% | 13,627,531 | 79.21M |
| 292 | ARDX | Ardelyx, Inc. | 1.57B | 1.28% | 2,927,368 | 427.68M |
| 293 | CMPS | COMPASS Pathways plc | 1.56B | 6.62% | 6,202,786 | - |
| 294 | QURE | uniQure N.V. | 1.56B | 0.65% | 1,012,820 | 18.09M |
| 295 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.55B | 2.35% | 1,021,736 | -665.00K |
| 296 | IMCR | Immunocore Holdings plc | 1.53B | 1.56% | 243,992 | 412.81M |
| 297 | PGEN | Precigen, Inc. | 1.53B | 0.23% | 1,856,941 | 31.60M |
| 298 | ALMR | Alamar Biosciences, Inc. | 1.52B | 9.13% | 337,041 | 87.16M |
| 299 | VIR | Vir Biotechnology, Inc. | 1.52B | 1.69% | 957,350 | 65.50M |
| 300 | MBX | MBX Biosciences, Inc. | 1.51B | 1.15% | 460,318 | - |
| 301 | GHRS | GH Research PLC | 1.49B | -3.42% | 310,061 | - |
| 302 | DMRA | Damora Therapeutics, Inc. | 1.49B | 2.24% | 255,148 | - |
| 303 | IMTX | Immatics N.V. | 1.48B | -1.38% | 408,343 | 43.00M |
| 304 | NVAX | Novavax, Inc. | 1.48B | -3.13% | 3,582,197 | 596.34M |
| 305 | ATRC | AtriCure, Inc. | 1.46B | -0.62% | 447,493 | 552.16M |
| 306 | URGN | UroGen Pharma Ltd. | 1.46B | -1.13% | 789,735 | 140.49M |
| 307 | BHVN | Biohaven Ltd. | 1.43B | 7.12% | 2,157,793 | - |
| 308 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | -0.15% | 1,645,105 | 114.48M |
| 309 | MAZE | Maze Therapeutics, Inc. | 1.43B | 2.88% | 440,145 | 20.00M |
| 310 | ENOV | Enovis Corporation | 1.42B | -7.07% | 1,445,212 | 2.28B |
| 311 | SLS | SELLAS Life Sciences Group, Inc. | 1.41B | -15.72% | 24,947,219 | - |
| 312 | WGS | GeneDx Holdings Corp. | 1.41B | 5.81% | 2,277,786 | 442.68M |
| 313 | AHCO | AdaptHealth Corp. | 1.40B | 0.48% | 754,715 | 3.29B |
| 314 | HCSG | Healthcare Services Group, Inc. | 1.39B | -2.93% | 468,306 | 1.85B |
| 315 | BCAX | Bicara Therapeutics Inc. | 1.37B | 2.01% | 429,537 | - |
| 316 | PAHC | Phibro Animal Health Corporation | 1.36B | -1.04% | 342,954 | 1.50B |
| 317 | MLTX | MoonLake Immunotherapeutics | 1.35B | 8.33% | 798,236 | - |
| 318 | AGL | agilon health, inc. | 1.34B | -0.46% | 310,732 | 5.82B |
| 319 | MPLT | MapLight Therapeutics, Inc. | 1.33B | 5.29% | 158,904 | - |
| 320 | NNNN | Anbio Biotechnology | 1.33B | -4.99% | 15,525 | 8.65M |
| 321 | ARDT | Ardent Health, Inc. | 1.32B | -2.54% | 342,459 | 6.43B |
| 322 | AHG | Akso Health Group | 1.29B | -5.63% | 6,847 | 14.84M |
| 323 | INSP | Inspire Medical Systems, Inc. | 1.29B | 1.36% | 1,141,238 | 915.25M |
| 324 | SVRA | Savara Inc. | 1.28B | -0.39% | 799,144 | - |
| 325 | ATEC | Alphatec Holdings, Inc. | 1.27B | -0.12% | 2,426,375 | 787.08M |
| 326 | KMTS | Kestra Medical Technologies, Ltd. | 1.26B | 3.85% | 290,326 | 83.72M |
| 327 | SEPN | Septerna, Inc. | 1.26B | -0.32% | 232,417 | 72.26M |
| 328 | AVBP | ArriVent BioPharma, Inc. | 1.26B | -0.81% | 475,357 | - |
| 329 | ZBIO | Zenas BioPharma, Inc. | 1.25B | 1.43% | 531,481 | 10.00M |
| 330 | FTRE | Fortrea Holdings Inc. | 1.24B | -4.09% | 1,115,850 | 2.71B |
| 331 | WVE | Wave Life Sciences Ltd. | 1.24B | 3.72% | 3,075,122 | 71.80M |
| 332 | HROW | Harrow, Inc. | 1.23B | 6.80% | 1,435,500 | 268.68M |
| 333 | OLMA | Olema Pharmaceuticals, Inc. | 1.23B | 0.72% | 1,080,617 | - |
| 334 | BLFS | BioLife Solutions, Inc. | 1.21B | 3.08% | 1,073,798 | 101.66M |
| 335 | PNTG | The Pennant Group, Inc. | 1.20B | -2.07% | 207,039 | 1.02B |
| 336 | IRMD | IRADIMED CORPORATION | 1.19B | 3.14% | 332,262 | 86.28M |
| 337 | AVLN | Avalyn Pharma Inc. | 1.19B | 1.36% | 189,902 | - |
| 338 | NEO | NeoGenomics, Inc. | 1.19B | 2.36% | 1,565,800 | 745.97M |
| 339 | TDOC | Teladoc Health, Inc. | 1.19B | 1.39% | 2,755,433 | 2.51B |
| 340 | IART | Integra LifeSciences Holdings Corporation | 1.18B | -1.75% | 1,072,830 | 1.64B |
| 341 | BFLY | Butterfly Network, Inc. | 1.17B | 2.05% | 4,443,550 | 102.92M |
| 342 | COAG | Hemab Therapeutics Holdings, Inc. | 1.16B | -0.64% | 193,386 | - |
| 343 | JBIO | Jade Biosciences, Inc. | 1.16B | 0.54% | 368,826 | - |
| 344 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.16B | 1.13% | 2,633,718 | 204.73M |
| 345 | AVNS | Avanos Medical, Inc. | 1.16B | -0.16% | 1,346,578 | 715.90M |
| 346 | COLL | Collegium Pharmaceutical, Inc. | 1.12B | 0.56% | 206,521 | 796.33M |
| 347 | CNMD | CONMED Corporation | 1.11B | 0.03% | 854,865 | 1.37B |
| 348 | CDNA | CareDx, Inc. | 1.11B | 1.99% | 670,240 | 412.82M |
| 349 | AORT | Artivion, Inc. | 1.11B | 0.44% | 638,543 | 458.69M |
| 350 | XERS | Xeris Biopharma Holdings, Inc. | 1.10B | 2.41% | 1,225,221 | 314.85M |
| 351 | CRVS | Corvus Pharmaceuticals, Inc. | 1.10B | 7.30% | 1,888,736 | - |
| 352 | DBVT | DBV Technologies S.A. | 1.10B | 0.16% | 167,113 | 5.74M |
| 353 | TNDM | Tandem Diabetes Care, Inc. | 1.08B | 4.79% | 2,775,914 | 1.03B |
| 354 | EYPT | EyePoint, Inc. | 1.07B | 2.24% | 559,607 | 7.61M |
| 355 | IVA | Inventiva S.A. | 1.07B | 1.36% | 119,433 | 7.94M |
| 356 | ALVO | Alvotech | 1.06B | 2.42% | 672,546 | 562.04M |
| 357 | AKTS | Aktis Oncology, Inc. | 1.06B | 0.47% | 147,266 | 8.28M |
| 358 | EVO | Evotec SE | 1.05B | 5.28% | 24,542 | 859.03M |
| 359 | MNKD | MannKind Corporation | 1.02B | 1.85% | 2,999,514 | 360.78M |
| 360 | CRON | Cronos Group Inc. | 1.01B | 2.25% | 1,707,712 | 159.54M |
| 361 | INNV | InnovAge Holding Corp. | 1.00B | -1.86% | 238,571 | 949.17M |
| 362 | AMN | AMN Healthcare Services, Inc. | 994.86M | -4.50% | 1,334,622 | 3.42B |
| 363 | LXRX | Lexicon Pharmaceuticals, Inc. | 990.35M | 0.90% | 1,620,463 | 69.64M |
| 364 | SDGR | Schrödinger, Inc. | 988.56M | 7.39% | 1,552,658 | 254.91M |
| 365 | KURA | Kura Oncology, Inc. | 988.06M | 7.64% | 5,224,175 | 71.64M |
| 366 | OMDA | Omada Health, Inc. | 977.33M | -0.48% | 422,668 | 283.30M |
| 367 | OPK | OPKO Health, Inc. | 966.52M | 4.07% | 3,321,162 | 581.12M |
| 368 | DRTS | Alpha Tau Medical Ltd. | 964.59M | -1.97% | 688,248 | - |
| 369 | ETON | Eton Pharmaceuticals, Inc. | 958.73M | 1.60% | 600,899 | 86.93M |
| 370 | USPH | U.S. Physical Therapy, Inc. | 956.50M | 0.98% | 297,387 | 787.69M |
| 371 | PCRX | Pacira BioSciences, Inc. | 923.89M | 2.09% | 404,074 | 734.86M |
| 372 | PHAT | Phathom Pharmaceuticals, Inc. | 919.80M | -2.44% | 588,114 | 204.89M |
| 373 | PHAR | Pharming Group N.V. | 915.65M | -0.47% | 5,860 | 369.49M |
| 374 | SPTX | Seaport Therapeutics, Inc. | 911.55M | 8.94% | 209,797 | - |
| 375 | AZTA | Azenta, Inc. | 900.65M | 5.22% | 1,394,095 | 596.48M |
| 376 | ANNX | Annexon, Inc. | 891.30M | 7.94% | 3,011,963 | - |
| 377 | JANX | Janux Therapeutics, Inc. | 880.00M | 0.21% | 633,806 | 13.73M |
| 378 | MGTX | MeiraGTx Holdings plc | 878.86M | -0.94% | 411,108 | 79.76M |
| 379 | ABUS | Arbutus Biopharma Corporation | 877.07M | 1.60% | 2,357,570 | 191.45M |
| 380 | SANA | Sana Biotechnology, Inc. | 876.62M | 1.29% | 2,063,991 | - |
| 381 | INMD | InMode Ltd. | 876.25M | -1.36% | 2,742,373 | 374.64M |
| 382 | ORIC | ORIC Pharmaceuticals, Inc. | 875.76M | 0.59% | 625,998 | - |
| 383 | AVR | Anteris Technologies Global Corp. | 869.98M | 4.41% | 2,204,086 | 1.85M |
| 384 | TALK | Talkspace, Inc. | 869.39M | - | 1,355,643 | 238.37M |
| 385 | GDRX | GoodRx Holdings, Inc. | 867.01M | 1.59% | 1,109,769 | 787.89M |
| 386 | OMER | Omeros Corporation | 865.61M | -3.39% | 961,002 | 9.89M |
| 387 | PSNL | Personalis, Inc. | 863.95M | 3.77% | 4,166,242 | 64.52M |
| 388 | CGEM | Cullinan Therapeutics, Inc. | 859.18M | -2.44% | 705,542 | - |
| 389 | EVMN | Evommune, Inc. | 848.23M | 5.70% | 582,625 | 10.00M |
| 390 | QDEL | QuidelOrtho Corporation | 844.89M | 4.03% | 1,859,667 | 2.66B |
| 391 | AURA | Aura Biosciences, Inc. | 843.79M | 2.41% | 823,141 | - |
| 392 | TBPH | Theravance Biopharma, Inc. | 841.86M | -1.33% | 269,436 | 109.78M |
| 393 | ODTX | Odyssey Therapeutics, Inc. | 841.35M | 5.13% | 408,052 | 2.98M |
| 394 | XNCR | Xencor, Inc. | 835.58M | -0.44% | 642,633 | 97.36M |
| 395 | CTMX | CytomX Therapeutics, Inc. | 818.56M | 1.08% | 1,597,194 | 35.54M |
| 396 | DRUG | Bright Minds Biosciences Inc. | 818.12M | 0.56% | 517,766 | - |
| 397 | NUTX | Nutex Health Inc. | 818.05M | -2.19% | 78,940 | 879.95M |
| 398 | SPRY | ARS Pharmaceuticals, Inc. | 817.27M | 5.51% | 2,126,691 | 98.99M |
| 399 | VOR | Vor Biopharma Inc. | 814.95M | -3.28% | 932,878 | - |
| 400 | AVTX | Avalo Therapeutics, Inc. | 814.34M | 1.90% | 1,363,536 | 59.00K |
| 401 | GERN | Geron Corporation | 808.32M | - | 7,513,589 | 196.12M |
| 402 | ESPR | Esperion Therapeutics, Inc. | 805.76M | - | 4,914,130 | 418.24M |
| 403 | CERT | Certara, Inc. | 804.27M | 10.71% | 5,787,096 | 419.75M |
| 404 | LBRX | LB Pharmaceuticals Inc | 802.95M | -0.11% | 156,076 | - |
| 405 | AMPH | Amphastar Pharmaceuticals, Inc. | 800.73M | 0.44% | 1,656,969 | 720.53M |
| 406 | ABSI | Absci Corporation | 793.56M | 2.83% | 2,604,911 | 1.84M |
| 407 | BVS | Bioventus Inc. | 793.16M | -13.21% | 1,189,490 | 576.30M |
| 408 | LMRI | Lumexa Imaging Holdings, Inc. | 785.94M | 10.54% | 940,813 | 1.03B |
| 409 | SSII | SS Innovations International, Inc. | 777.77M | -1.39% | 38,410 | 48.47M |
| 410 | RLMD | Relmada Therapeutics, Inc. | 756.24M | 0.56% | 723,015 | - |
| 411 | ANRO | Alto Neuroscience, Inc. | 755.04M | 3.66% | 225,633 | - |
| 412 | BIOA | BioAge Labs, Inc. | 744.14M | 3.91% | 315,593 | 10.32M |
| 413 | SGP | SpyGlass Pharma, Inc. | 737.06M | 0.73% | 79,866 | - |
| 414 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 729.10M | 3.41% | 496,973 | - |
| 415 | TENX | Tenax Therapeutics, Inc. | 727.74M | 3.00% | 443,202 | - |
| 416 | CBLL | CeriBell, Inc. | 711.05M | 3.54% | 563,138 | 95.07M |
| 417 | HSTM | HealthStream, Inc. | 691.52M | -1.05% | 225,642 | 311.78M |
| 418 | DSGN | Design Therapeutics, Inc. | 687.65M | -0.81% | 1,127,464 | - |
| 419 | ALLO | Allogene Therapeutics, Inc. | 676.50M | 3.16% | 4,331,252 | 22.00K |
| 420 | CBIO | Crescent Biopharma, Inc. | 672.22M | 6.98% | 249,462 | 11.88M |
| 421 | SIBN | SI-BONE, Inc. | 656.81M | -0.07% | 770,938 | 206.22M |
| 422 | TLRY | Tilray Brands, Inc. | 651.28M | 0.92% | 2,310,833 | 858.28M |
| 423 | SLDB | Solid Biosciences Inc. | 639.92M | 0.46% | 604,266 | - |
| 424 | ACRS | Aclaris Therapeutics, Inc. | 634.07M | 0.22% | 475,748 | 8.37M |
| 425 | IRWD | Ironwood Pharmaceuticals, Inc. | 633.76M | -1.79% | 2,076,515 | 361.51M |
| 426 | CRMD | CorMedix Inc. | 632.32M | 1.64% | 1,385,868 | 400.05M |
| 427 | CSTL | Castle Biosciences, Inc. | 622.98M | 2.55% | 251,637 | 339.92M |
| 428 | ZVRA | Zevra Therapeutics, Inc. | 620.12M | 2.44% | 2,440,989 | 122.29M |
| 429 | BWAY | BrainsWay Ltd. | 608.13M | -1.31% | 67,568 | 56.22M |
| 430 | EIKN | Eikon Therapeutics, Inc. | 605.81M | 4.97% | 185,201 | - |
| 431 | CABA | Cabaletta Bio, Inc. | 601.65M | 7.27% | 3,600,742 | - |
| 432 | ARVN | Arvinas, Inc. | 587.14M | - | 781,811 | 89.40M |
| 433 | TRAX | First Tracks Biotherapeutics, Inc. | 584.80M | 3.68% | 307,200 | - |
| 434 | CADL | Candel Therapeutics, Inc. | 581.03M | 2.85% | 1,670,868 | - |
| 435 | TCMD | Tactile Systems Technology, Inc. | 578.12M | 3.18% | 420,538 | 343.52M |
| 436 | ALT | Altimmune, Inc. | 569.81M | 3.90% | 3,045,382 | 36.00K |
| 437 | GYRE | Gyre Therapeutics, Inc. | 562.39M | 1.90% | 97,437 | 117.05M |
| 438 | NPCE | NeuroPace, Inc. | 555.05M | 0.06% | 215,079 | 99.53M |
| 439 | CERS | Cerus Corporation | 549.01M | 1.86% | 1,904,824 | 216.56M |
| 440 | VALN | Valneva SE | 543.39M | -0.84% | 11,744 | 180.25M |
| 441 | RIGL | Rigel Pharmaceuticals, Inc. | 540.08M | 1.28% | 214,864 | 299.77M |
| 442 | CTNM | Contineum Therapeutics, Inc. | 539.49M | 7.77% | 155,856 | - |
| 443 | FBRX | Forte Biosciences, Inc. | 539.29M | 8.67% | 227,732 | - |
| 444 | KYTX | Kyverna Therapeutics, Inc. | 538.72M | 3.85% | 822,528 | - |
| 445 | MDXG | MiMedx Group, Inc. | 537.69M | -4.75% | 1,474,294 | 389.42M |
| 446 | TECX | Tectonic Therapeutic, Inc. | 537.21M | -1.28% | 103,169 | - |
| 447 | AGMB | AgomAb Therapeutics NV | 535.82M | 1.68% | 27,861 | - |
| 448 | PHR | Phreesia, Inc. | 533.50M | -0.79% | 1,207,464 | 480.59M |
| 449 | PRME | Prime Medicine, Inc. | 532.82M | 4.24% | 1,994,307 | 4.03M |
| 450 | AQST | Aquestive Therapeutics, Inc. | 530.65M | 1.44% | 1,265,017 | 50.27M |
| 451 | PROK | ProKidney Corp. | 528.43M | 3.55% | 873,957 | 889.00K |
| 452 | DNA | Ginkgo Bioworks Holdings, Inc. | 527.82M | 4.66% | 651,098 | 151.40M |
| 453 | XOMA | XOMA Royalty Corporation | 524.47M | -0.38% | 52,217 | 48.56M |
| 454 | CLYM | Climb Bio, Inc. | 521.15M | 3.71% | 604,048 | - |
| 455 | CTKB | Cytek Biosciences, Inc. | 511.40M | 5.04% | 723,719 | 204.17M |
| 456 | STRO | Sutro Biopharma, Inc. | 507.31M | -1.64% | 364,695 | 99.61M |
| 457 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 458 | SRTA | Strata Critical Medical, Inc. | 501.85M | 4.69% | 1,306,396 | 228.58M |
| 459 | ANGO | AngioDynamics, Inc. | 498.52M | 1.27% | 342,710 | 313.73M |
| 460 | FLGT | Fulgent Genetics, Inc. | 493.60M | 5.91% | 388,299 | 320.35M |
| 461 | PRTA | Prothena Corporation plc | 492.12M | 0.53% | 388,701 | 57.94M |
| 462 | ANL | Adlai Nortye Ltd. | 483.20M | 6.34% | 96,476 | 5.00M |
| 463 | KIDS | OrthoPediatrics Corp. | 473.37M | -0.38% | 141,425 | 243.30M |
| 464 | BBNX | Beta Bionics, Inc. | 472.80M | 4.95% | 837,950 | 110.24M |
| 465 | ACHV | Achieve Life Sciences, Inc. | 472.23M | 0.66% | 840,628 | - |
| 466 | UPB | Upstream Bio, Inc. | 460.39M | 0.59% | 597,539 | 3.32M |
| 467 | STTK | Shattuck Labs, Inc. | 460.29M | -1.30% | 963,665 | 1.00M |
| 468 | IMMX | Immix Biopharma, Inc. | 459.61M | -3.02% | 5,931,826 | - |
| 469 | OCGN | Ocugen, Inc. | 457.00M | -0.74% | 4,107,760 | 4.47M |
| 470 | KMDA | Kamada Ltd. | 455.37M | -0.64% | 24,781 | 181.68M |
| 471 | FDMT | 4D Molecular Therapeutics, Inc. | 454.28M | 2.60% | 555,179 | 88.24M |
| 472 | TOI | The Oncology Institute, Inc. | 446.92M | 6.43% | 2,191,491 | 545.76M |
| 473 | WEAV | Weave Communications, Inc. | 446.36M | -4.75% | 1,680,797 | 248.72M |
| 474 | CATX | Perspective Therapeutics, Inc. | 441.36M | 2.65% | 917,903 | 618.00K |
| 475 | FULC | Fulcrum Therapeutics, Inc. | 440.11M | 4.02% | 402,630 | 80.00M |
| 476 | AUTL | Autolus Therapeutics plc | 439.14M | 1.85% | 667,605 | 92.62M |
| 477 | NGNE | Neurogene Inc. | 436.29M | 2.45% | 135,591 | 925.00K |
| 478 | PRLD | Prelude Therapeutics Incorporated | 435.50M | -3.78% | 197,108 | 16.72M |
| 479 | ADCT | ADC Therapeutics SA | 432.45M | 4.94% | 764,629 | 79.18M |
| 480 | SGMT | Sagimet Biosciences Inc. | 432.26M | 5.26% | 674,515 | - |
| 481 | EVH | Evolent Health, Inc. | 431.93M | -0.52% | 3,241,267 | 1.89B |
| 482 | EBS | Emergent BioSolutions Inc. | 431.86M | 2.70% | 554,222 | 676.80M |
| 483 | REPL | Replimune Group, Inc. | 431.03M | 1.16% | 4,551,888 | - |
| 484 | VTVT | vTv Therapeutics Inc. | 430.86M | -5.14% | 25,110 | 36.84M |
| 485 | NRC | NRC Health | 429.10M | -1.14% | 66,353 | 138.64M |
| 486 | VREX | Varex Imaging Corporation | 426.94M | - | 298,506 | 857.50M |
| 487 | EOLS | Evolus, Inc. | 424.76M | -2.12% | 531,601 | 301.79M |
| 488 | OVID | Ovid Therapeutics Inc. | 422.21M | 2.09% | 726,678 | 7.12M |
| 489 | ZURA | Zura Bio Limited | 421.27M | 8.69% | 809,528 | - |
| 490 | OFIX | Orthofix Medical Inc. | 420.79M | -14.32% | 1,562,126 | 825.37M |
| 491 | ASMB | Assembly Biosciences, Inc. | 419.88M | 0.61% | 63,893 | 71.10M |
| 492 | MNPR | Monopar Therapeutics Inc. | 419.88M | -3.49% | 158,015 | - |
| 493 | MOBI | Mobia Medical, Inc. | 415.88M | -1.41% | 63,671 | 32.04M |
| 494 | LXEO | Lexeo Therapeutics, Inc. | 411.45M | 2.34% | 666,223 | - |
| 495 | IPSC | Century Therapeutics, Inc. | 409.40M | 0.89% | 499,144 | 109.16M |
| 496 | LAB | Standard BioTools Inc. | 405.98M | -1.89% | 1,953,184 | 86.26M |
| 497 | LYEL | Lyell Immunopharma, Inc. | 405.05M | 0.81% | 69,783 | 31.00K |
| 498 | CCRN | Cross Country Healthcare, Inc. | 404.66M | -0.46% | 4,060,748 | 1.00B |
| 499 | ENTA | Enanta Pharmaceuticals, Inc. | 402.15M | 1.62% | 114,883 | 69.21M |
| 500 | CTEV | Claritev Corporation | 401.48M | 10.88% | 228,469 | 978.76M |